Physician
Pediatricare of Northern Virginia, P.C.
Pediatricare of Northern Virginia, P.C. was paid $8.59M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 26% of everything it billed.
33Billing provider infoPEDIATRICARE OF NORTHERN VIRGINIA, P.C.
MANASSAS, VA 20110
MANASSAS, VA 20110
33aNPI1104994623assigned 12/01/2006
33bProvider typePediatrics Physician
28Total paid$8.59M
24GClaims260,537
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Virginia
Rank by total paid#9 of 817
Median peer was paid$29K
This provider vs. median294×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,821 | $1.13M | |
| 2019 | 35,407 | $1.18M | |
| 2020 | 31,580 | $1.01M | |
| 2021 | 41,666 | $1.12M | |
| 2022 | 46,164 | $1.50M | |
| 2023 | 42,809 | $1.47M | |
| 2024incomplete | 32,090 | $1.19M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 26,530 | 25,259 | $2.24M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 30,503 | 29,109 | $1.89M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 11,649 | 11,510 | $907K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.0% | 8,824 | 8,743 | $685K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.8% | 9,151 | 8,773 | $667K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.0% | 5,020 | 4,984 | $425K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.4% | 13,586 | 7,570 | $208K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.0% | 5,843 | 5,723 | $176K |
| 90670 | 1.8% | 5,887 | 5,775 | $151K | |
| 90686 | 1.5% | 10,933 | 10,839 | $133K | |
| 87428 | 1.5% | 3,266 | 3,232 | $129K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 8,921 | 8,761 | $121K |
51 more codes
| 90671 | <1% | 1,320 | $75K | |
| 90648 | <1% | 6,785 | $74K | |
| 90723 | <1% | 4,207 | $74K | |
| 90680 | <1% | 3,713 | $65K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 25,800 | $63K |
| 90651 | <1% | 874 | $48K | |
| 0002A | <1% | 969 | $38K | |
| 0001A | <1% | 916 | $36K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 979 | $35K |
| 90633 | <1% | 2,606 | $35K | |
| 99174 | <1% | 5,826 | $29K | |
| 92551 | <1% | 2,519 | $25K | |
| 90734 | <1% | 662 | $24K | |
| 90688 | <1% | 1,901 | $22K | |
| 0072A | <1% | 519 | $21K | |
| 96127 | <1% | 4,193 | $20K | |
| 90461 | <1% | 12,638 | $19K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 236 | $19K |
| 0071A | <1% | 478 | $19K | |
| 99000 | <1% | 6,572 | $15K | |
| 83655 | <1% | 1,160 | $14K | |
| 99051 | <1% | 4,594 | $13K | |
| 90656 | <1% | 621 | $10K | |
| 85018 | <1% | 3,767 | $9K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 883 | $8K |
| 90672 | <1% | 452 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,736 | $6K |
| 0004A | <1% | 145 | $6K | |
| 99173 | <1% | 2,390 | $6K | |
| 81002 | <1% | 1,621 | $5K | |
| 90698 | <1% | 273 | $4K | |
| 90716 | <1% | 137 | $2K | |
| 99188 | <1% | 112 | $2K | |
| 90685 | <1% | 184 | $2K | |
| 90710 | <1% | 55 | $2K | |
| 90707 | <1% | 126 | $2K | |
| 69210 | <1% | 39 | $2K | |
| 90715 | <1% | 88 | $1K | |
| 36416 | <1% | 6,288 | $969.24 | |
| 90696 | <1% | 54 | $795.04 | |
| 90744 | <1% | 61 | $755.48 | |
| 90700 | <1% | 55 | $663.95 | |
| 0003A | <1% | 12 | $480.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 30 | $458.25 |
| 99072 | <1% | 6,738 | $362.84 | |
| 90660 | <1% | 16 | $300.43 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,155 | $260.00 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 29 | $22.60 |
| 91300 | <1% | 1,851 | $12.95 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 27 | $3.05 |
| 90473 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGIANCOLA, FRANK (PRESIDENT)